Quarterly 13F snapshot: US-listed longs only, no performance figures — 13F data cannot support them.
Reported portfolio value by quarter (47 quarters reported)
$127M in Q4 2014 → $604M now. Hover for any quarter.
As reported for the quarter ended June 30, 2026. Activity is the change in share count since the prior quarter's filing.
| Holding | % of portfolio | Activity | Shares | Value |
|---|---|---|---|---|
| Anteris Technologies Global | 9.0% | Added 3.0% | 5,545,984 | $54.6M |
| Cencora Inc | 8.1% | Added 72% | 173,588 | $49.1M |
| Maximus Inc | 6.4% | Trimmed 7.0% | 715,267 | $38.5M |
| Allogene Therapeutics Inc | 4.6% | New | 13,323,431 | $27.7M |
| GM Globus Med Inc | 3.9% | New | 301,816 | $23.8M |
| Gsk PLC | 3.8% | Added 13% | 436,700 | $22.9M |
| Tyra Biosciences Inc | 3.7% | Added 15% | 695,315 | $22.2M |
| WH Waystar Hldg Corp | 3.1% | Trimmed 44% | 925,834 | $19M |
| SL Sellas Life Sciences Group I Put | 3.0% | New | 1,230,700 | $18.2M |
| Ideaya Biosciences Inc | 3.0% | New | 480,383 | $17.9M |
| Oruka Therapeutics Inc | 2.8% | Added 34% | 177,118 | $16.9M |
| The Cigna Group | 2.6% | New | 57,750 | $15.9M |
| Sanofi Sa | 2.6% | Added 52% | 364,200 | $15.5M |
| IP Icon Pub Ltd Co | 2.5% | Trimmed 71% | 88,186 | $15.3M |
| Viatris Inc | 2.5% | New | 954,299 | $15.2M |
| CC Cross Ctry Healthcare Inc | 2.4% | Unchanged | 1,098,393 | $14.5M |
| Rapport Therapeutics Inc | 2.1% | Trimmed 16% | 307,657 | $12.8M |
| Abbott Laboratories | 1.9% | Trimmed 31% | 128,656 | $11.7M |
| Celcuity Inc | 1.9% | Trimmed 43% | 110,022 | $11.5M |
| Zimmer Biomet Holdings Inc | 1.9% | Added 110% | 131,445 | $11.3M |
| Regeneron Pharmaceuticals | 1.9% | New | 18,000 | $11.2M |
| Bristol-myers Squibb Co | 1.8% | New | 193,500 | $11.1M |
| Medtronic PLC | 1.8% | New | 142,500 | $11.1M |
| Vir Biotechnology Inc | 1.8% | Trimmed 28% | 1,075,274 | $11M |
| SH Senseonics Hldgs Inc | 1.5% | Added 1276% | 1,592,692 | $9.05M |
| Eyepoint Inc | 1.5% | Trimmed 14% | 623,130 | $8.91M |
| Cybin Inc | 1.4% | New | 1,300,000 | $8.59M |
| Ani Pharmaceuticals Inc | 1.3% | Trimmed 63% | 97,305 | $8.05M |
| Protara Therapeutics Inc | 1.2% | Trimmed 2.4% | 1,921,872 | $7.34M |
| Relmada Therapeutics Inc | 1.1% | Added 4.0% | 1,003,562 | $6.94M |
| Tango Therapeutics Inc | 1.1% | New | 208,500 | $6.52M |
| Aquestive Therapeutics Inc | 1.0% | Trimmed 23% | 1,486,175 | $6.18M |
| Dianthus Therapeutics Inc | 1.0% | Trimmed 84% | 59,254 | $5.78M |
| Sionna Therapeutics Inc | 0.9% | Trimmed 57% | 127,808 | $5.62M |
| Ocular Therapeutix Inc | 0.9% | Trimmed 44% | 539,493 | $5.3M |
| Zenas Biopharma Inc | 0.9% | Trimmed 37% | 208,557 | $5.29M |
| Bright Minds Biosciences Inc | 0.9% | Trimmed 14% | 73,952 | $5.19M |
| Onkure Therapeutics Inc | 0.8% | Unchanged | 1,078,965 | $4.92M |
| Savara Inc | 0.6% | Added 0.6% | 617,675 | $3.8M |
| Pmv Pharmaceuticals Inc | 0.6% | Trimmed 14% | 2,634,137 | $3.53M |
| AH Aveanna Healthcare Hldgs Inc | 0.5% | New | 369,036 | $3.16M |
| Ovid Therapeutics Inc | 0.4% | Trimmed 20% | 1,005,334 | $2.7M |
| Immunome Inc | 0.4% | Trimmed 25% | 124,168 | $2.63M |
| Hims & Hers Health Inc Call | 0.4% | New | 75,000 | $2.6M |
| An2 Therapeutics Inc | 0.4% | Trimmed 19% | 529,933 | $2.56M |
| Serina Therapeutics Inc | 0.3% | Unchanged | 1,000,000 | $1.94M |
| Aligos Therapeutics Inc | 0.3% | Unchanged | 327,237 | $1.89M |
| Ibio Inc | 0.3% | Unchanged | 904,268 | $1.58M |
| Xilio Therapeutics Inc | 0.2% | Unchanged | 152,464 | $1.46M |
| Artivion Inc | 0.2% | New | 48,481 | $1.09M |
| BO Bridgebio Oncology Therapeut | 0.2% | Unchanged | 130,628 | $995K |
| Tela Bio Inc | 0.1% | Unchanged | 636,300 | $477K |
| AM Adagio Med Hldgs Inc | 0.1% | Trimmed 46% | 698,989 | $455K |
| NM Neuroone Med Technologies Co | 0.0% | New | 82,767 | $252K |
| Enveric Biosciences Inc | 0.0% | New | 180,000 | $248K |
| MM Modular Med Inc | 0.0% | Unchanged | 26,190 | $118K |
| QI Qt Imaging Hldgs Inc | 0.0% | New | 15,236 | $62K |
| Rocket Pharmaceuticals Inc | 0.0% | Unchanged | 400,000 | $1.48K |
| Humacyte Inc | 0.0% | Unchanged | 49,998 | $477 |
What changed each quarter, from the filings' own share counts. Largest moves first; most recent 8 quarters.
quarter ended June 30, 2026 · filed August 14, 2026
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| IP Icon Pub Ltd Co | Trimmed | −218,172 | −$37.9M | 2.5% |
| Dianthus Therapeutics Inc | Trimmed | −310,791 | −$30.3M | 1.0% |
| Allogene Therapeutics Inc | New | +13,323,431 | +$27.7M | 4.6% |
| Corcept Therapeutics Inc | Exited | −674,759 | −$27.2M | — |
| Livanova PLC | Exited | −421,615 | −$26.8M | — |
| GM Globus Med Inc | New | +301,816 | +$23.8M | 3.9% |
| Cencora Inc | Added | +72,694 | +$20.6M | 8.1% |
| SL Sellas Life Sciences Group I | New | +1,230,700 | +$18.2M | 3.0% |
| Ideaya Biosciences Inc | New | +480,383 | +$17.9M | 3.0% |
| Embecta Corp | Exited | −1,847,850 | −$16.3M | — |
Showing the 10 largest of 82 changes.
quarter ended March 31, 2026 · filed May 14, 2026
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| The Cigna Group | Exited | −172,203 | −$47.4M | — |
| Sanofi Sa | Trimmed | −732,015 | −$35.3M | 1.7% |
| Celcuity Inc | Trimmed | −283,224 | −$32.3M | 3.2% |
| Zimmer Biomet Holdings Inc | Trimmed | −323,029 | −$29.2M | 0.8% |
| Rhythm Pharmaceuticals Inc | Exited | −265,700 | −$28.4M | — |
| Corcept Therapeutics Inc | New | +674,759 | +$27.2M | 3.9% |
| Cencora Inc | Added | +84,994 | +$26.7M | 4.5% |
| Kenvue Inc | Exited | −1,465,442 | −$25.3M | — |
| WH Waystar Hldg Corp | Added | +1,028,511 | +$24.8M | 5.7% |
| Gsk PLC | New | +385,879 | +$21.3M | 3.1% |
Showing the 10 largest of 79 changes.
quarter ended December 31, 2025 · filed February 17, 2026
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| The Cigna Group | New | +172,203 | +$47.4M | 7.5% |
| Zimmer Biomet Holdings Inc | New | +385,642 | +$34.7M | 5.5% |
| Celcuity Inc | Trimmed | −309,459 | −$30.9M | 7.5% |
| Rhythm Pharmaceuticals Inc | New | +265,700 | +$28.4M | 4.5% |
| Organon & Co | New | +3,421,765 | +$24.5M | 3.9% |
| Icon PLC | New | +127,202 | +$23.2M | 3.6% |
| WH Waystar Hldg Corp | New | +613,725 | +$20.1M | 3.2% |
| Livanova PLC | New | +322,382 | +$19.8M | 3.1% |
| Sanofi Sa | Added | +408,983 | +$19.8M | 7.4% |
| Disc Medicine Inc | Trimmed | −227,201 | −$18M | 0.7% |
Showing the 10 largest of 61 changes.
quarter ended September 30, 2025 · filed November 13, 2025
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Celcuity Inc | New | +786,526 | +$38.9M | 9.8% |
| Alkermes PLC | New | +674,840 | +$20.2M | 5.1% |
| Bright Minds Biosciences Inc | Trimmed | −321,574 | −$19.5M | 2.9% |
| Sanofi Sa | Added | +375,203 | +$17.7M | 6.7% |
| Henry Schein Inc | New | +219,207 | +$14.5M | 3.7% |
| GM Globus Med Inc | Exited | −245,570 | −$14.5M | — |
| Kenvue Inc | New | +844,000 | +$13.7M | 3.5% |
| Dianthus Therapeutics Inc | Added | +341,680 | +$13.4M | 5.8% |
| Neurocrine Biosciences Inc | Exited | −100,725 | −$12.7M | — |
| Gsk PLC | New | +268,873 | +$11.6M | 2.9% |
Showing the 10 largest of 49 changes.
quarter ended June 30, 2025 · filed August 13, 2025
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Icon PLC | Exited | −203,311 | −$35.6M | — |
| Zimmer Biomet Holdings Inc | Exited | −187,685 | −$21.2M | — |
| Labcorp Holdings Inc | Exited | −83,873 | −$19.5M | — |
| Teleflex Incorporated | Exited | −107,780 | −$14.9M | — |
| CD Centene Corp Del | New | +262,500 | +$14.2M | 5.4% |
| Disc Medicine Inc | Added | +211,276 | +$11.2M | 5.8% |
| Neurocrine Biosciences Inc | Trimmed | −86,848 | −$10.9M | 4.8% |
| Embecta Corp | Trimmed | −1,076,444 | −$10.4M | 0.1% |
| IL Idexx Labs Inc | New | +18,000 | +$9.65M | 3.7% |
| S Sanofi | New | +187,500 | +$9.06M | 3.5% |
Showing the 10 largest of 59 changes.
quarter ended March 31, 2025 · filed May 15, 2025
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| The Cigna Group | Exited | −98,003 | −$27.1M | — |
| Merck & Co Inc | New | +270,596 | +$24.3M | 7.2% |
| Neurocrine Biosciences Inc | New | +187,573 | +$20.7M | 6.2% |
| S Sanofi | Exited | −387,000 | −$18.7M | — |
| GM Globus Med Inc | New | +207,000 | +$15.2M | 4.5% |
| Biomarin Pharmaceutical Inc | New | +141,134 | +$9.98M | 3.0% |
| Viatris Inc | Exited | −730,000 | −$9.09M | — |
| Organon & Co | Exited | −606,410 | −$9.05M | — |
| Embecta Corp | Added | +682,039 | +$8.7M | 4.2% |
| HM Haemonetics Corp Mass | New | +133,966 | +$8.51M | 2.5% |
Showing the 10 largest of 47 changes.
quarter ended December 31, 2024 · filed February 14, 2025
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Icon PLC | New | +195,500 | +$41M | 11.5% |
| Intuitive Surgical Inc | Exited | −59,000 | −$29M | — |
| Teva Pharmaceutical Industries Ltd | Exited | −1,349,274 | −$24.3M | — |
| The Cigna Group | Added | +71,500 | +$19.7M | 7.6% |
| S Sanofi | New | +387,000 | +$18.7M | 5.3% |
| Maximus Inc | Added | +226,281 | +$16.9M | 8.0% |
| Bright Minds Biosciences Inc | New | +451,793 | +$16.3M | 4.6% |
| Labcorp Holdings Inc | Trimmed | −60,000 | −$13.8M | 7.3% |
| Anteris Technologies Global | New | +2,370,000 | +$13.2M | 3.7% |
| Kenvue Inc | Exited | −474,741 | −$11M | — |
Showing the 10 largest of 46 changes.
quarter ended September 30, 2024 · filed November 14, 2024
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Insmed Inc | Exited | −1,362,700 | −$91.3M | — |
| Intuitive Surgical Inc | New | +59,000 | +$29M | 11.5% |
| Teva Pharmaceutical Industries Ltd | New | +1,349,274 | +$24.3M | 9.6% |
| Teleflex Incorporated | Trimmed | −71,806 | −$17.8M | 3.9% |
| Labcorp Holdings Inc | Trimmed | −72,609 | −$16.2M | 15.4% |
| Maximus Inc | New | +155,142 | +$14.5M | 5.7% |
| Smith & Nephew PLC | Exited | −579,619 | −$14.4M | — |
| Pacira Biosciences Inc | Exited | −455,500 | −$13M | — |
| Organon & Co | Exited | −608,096 | −$12.6M | — |
| Gsk PLC | Exited | −312,000 | −$12M | — |
Showing the 10 largest of 43 changes.
Loading...
